MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience to Participate in the 40th Annual William Blair Growth Stock Conference
29 mai 2020 08h00 HE | Meridian Bioscience Inc.
CINCINNATI, May 29, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month
26 mai 2020 08h00 HE | Meridian Bioscience Inc.
CINCINNATI, May 26, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that its...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics
20 mai 2020 16h20 HE | Meridian Bioscience Inc.
CINCINNATI, May 20, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc.’s (NASDAQ: VIVO) Board of Directors announced that Tony Serafini-Lamanna has been promoted to Executive Vice President of...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Reports Second Quarter 2020 Operating Results; Raises Guidance on Strength of COVID-19 Related Products
08 mai 2020 07h30 HE | Meridian Bioscience Inc.
CINCINNATI, May 08, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2020. Second Quarter Fiscal 2020...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Partners with QuantuMDx on COVID-19 Assay
06 mai 2020 08h00 HE | Meridian Bioscience Inc.
CINCINNATI, May 06, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, is pleased to announce its...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience
30 avr. 2020 10h50 HE | Meridian Bioscience Inc.
CINCINNATI, April 30, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, has completed its previously...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience Simplifies COVID-19 Sample Prep and Eliminates Dependence on Reagents in Short Supply
27 avr. 2020 11h56 HE | Meridian Bioscience Inc.
CINCINNATI, April 27, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step RT-qPCR Mix) that...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience To Hold Second Quarter 2020 Financial Results Conference Call On May 8, 2020
16 avr. 2020 09h00 HE | Meridian Bioscience Inc.
CINCINNATI, April 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report second quarter 2020...
MBI_Logo_Tagline_Blue.jpg
Meridian Bioscience offers SARS-CoV-2 antigens for COVID-19 Antibody Tests
14 avr. 2020 09h33 HE | Meridian Bioscience Inc.
CINCINNATI, April 14, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), announced today the launch of several novel recombinant antigens critical for the development of antibody...
2018_MER_LOGO_TM_BLU_sm.jpg
MERIDIAN BIOSCIENCE ANNOUNCES BETTER-THAN-EXPECTED PRELIMINARY SECOND QUARTER FISCAL 2020 REVENUE RESULTS WITH DOUBLE-DIGIT GROWTH
02 avr. 2020 07h30 HE | Meridian Bioscience Inc.
CINCINNATI, April 02, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today provided a business update...